Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine

Add time:07/12/2019    Source:sciencedirect.com

Aminopeptidase N (APN) is involved in different physiological and pathological processes of tumor cells, including proliferation, invasion, apoptosis and metastasis. Herein one series of compounds derived from commercially available (1S,2S)-2-amino-1-(4-nitrophenyl) propane-1,3-diol have been designed and synthesized. Furthermore, preliminary activity evaluation showed that some compounds elicited moderate inhibitory activity against APN with compounds 10e (IC50 = 6.1 ± 0.5 μM) possessing the best efficacy, which could be used as the lead compound in the future for anticancer agents research.

We also recommend Trading Suppliers and Manufacturers of Propanamide, N-(2-aminophenyl)-N-methyl- (cas 169330-11-4). Pls Click Website Link as below: cas 169330-11-4 suppliers

Prev:Dichloro-substituted phenyl amino propanamides exhibit anticonvulsant effect and reduce inward sodium ion current (NaV1.6)
Next:Design and synthesis of potent antitumor water-soluble phenyl N-mustard-benzenealkylamide conjugates via a bioisostere approach)